Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.

The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...

It's a terminal disease, currently with no cure. ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully ...

DURHAM -- August is the month the Ice Bucket Challenge kicks off, and Tuesday the Duke ALS Clinic joined in with an Ice Bucket Challenge of its own. The director of the clinic and leading ALS ...

On Monday, the 52-year-old actor -- who revealed his diagnosis in April -- posted a video on Instagram in collaboration with the organization, I AM ALS, for its Push for Progress campaign, which hopes ...

Erik P Pioro consults for MT Pharma, which manufactures edaravone (Radicava) and for Biogen, which manufactures tofersen (Qalsody). He has received funding support for ALS research from the ALS ...

Eric Dane revealed he’s not going down without a fight as he uses his own ALS diagnosis to bring about changes in fighting the disease. “ALS is the last thing they want to diagnose anybody with,” Dane ...

The ALS Network’s 23rd annual Inland Empire Walk and Roll to Cure ALS, formerly the Walk to Defeat ALS, will be held Oct. 19 at Miller Park Amphitheater, 17002 Arrow Blvd., Fontana. The Walk and Roll ...